Locked out of longevity

david-rawson-mackenzie

Despite increased scrutiny from the UK Financial Services Authority (FSA), the US Securities and Exchange Commission (SEC), the Financial Industry Regulatory Authority (Finra), the US Congress and various regional Asian regulators, dealers and institutional investors alike say demand for life settlement products is increasing.

Recent highlights include a massive series of longevity swaps traded by UK insurance companies, BMW’s £3 billion ($4.6 billion) swap with Deutsche Bank, the largest ever

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: